Dermatology · Centennial, CO
NPI
1205982808
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5555 E Arapahoe Rd
Centennial, CO, 80122
Phone (303) 338-4545
Groups this clinician bills Medicare through
Medicare paid, 2022
$1,112
23 services
Medicare patients, 2022
11
Average age 73
Drug cost, 2024
$139K
1,340 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Renee A D'Ambrosia prescribed most often to Medicare patients was Retin-A (Tretinoin), with 293 prescriptions and refills. In total Renee A D'Ambrosia wrote 1,340 Medicare prescriptions that cost $139K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-07-29.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Retin-A Tretinoin | 293 | 374 | 146 | $11K |
| Clobetasol Propionate Generic | 196 | 211 | 103 | $5,384 |
| Triamcinolone Acetonide Generic | 106 | 114 | 74 | $3,143 |
| Fluorouracil Generic | 95 | 95 | 77 | $3,878 |
| Ketoconazole Generic | 75 | 77 | 31 | $1,201 |
| Doxycycline Hyclate Generic | 63 | 125 | 24 | $1,581 |
| Tacrolimus Generic | 62 | 62 | 41 | $3,208 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 57 | 83 | 39 | $1,994 |
| Hydrocortisone Generic | 49 | 59 | 34 | $715 |
| Metronidazole Generic | 26 | 28 | 13 | $441 |
| Doxycycline Monohydrate Generic | 24 | 38 | 13 | $841 |
| Mupirocin Generic | 22 | 22 | 16 | $259 |
| Acyclovir Generic | 21 | 31 | 12 | $260 |
| Nystatin Generic | 20 | 20 | 15 | $679 |
| Tretinoin Generic | 20 | 20 | 19 | $1,598 |
Brand drugs: 384 claims; generic drugs: 956 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Renee A D'Ambrosia were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.